Fiche publication
Date publication
août 2014
Journal
The American journal of gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Roblin X, Rinaudo M, Del Tedesco E, Phelip JM, Genin C, Peyrin-Biroulet L, Paul S
Lien Pubmed
Résumé
Several decision algorithms based on the measurement of infliximab (IFX) trough levels and antibodies to IFX have been proposed. Whether such algorithms can be extrapolated to the pharmacokinetics of adalimumab (ADA) has yet to be determined.
Mots clés
Adalimumab, Adult, Algorithms, Anti-Inflammatory Agents, administration & dosage, Antibodies, Monoclonal, Humanized, administration & dosage, Enzyme-Linked Immunosorbent Assay, Female, Humans, Inflammatory Bowel Diseases, drug therapy, Male, Phenotype, Predictive Value of Tests, Prospective Studies, Treatment Outcome
Référence
Am. J. Gastroenterol.. 2014 Aug;109(8):1250-6
